why choose us

First received: January 16, 2023

Clinical Trial: Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Superficial Basal Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Single-Arm, Open-Label, Single Center Study to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects With Superficial Basal Cell Carcinoma (sBCC) on the Neck, Trunk, or E

Brief Summary: This is a Phase 2, Single-Arm, Open-Label, Single Center, Proof of Concept Study to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell carcinoma (sBCC) on the neck, trunk, or extremities (excluding, axilla, anogenital, and face/scalp).

Read more